Stock Evaluator: Palatin Technologies, Inc. (PTN)

Palatin Technologies, Inc. PTN

$12.70 -0.38 -2.91%
September 4, 2026 4:00:00 PM EST November 10, 2021 Volume: 257,715
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Biotechnology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.

Commentary & Analysis


Financial Summary

Share Statistics PTN Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $22.7 $282.4 11%
Shares Out (Mil) 3.9 54.0 12%
Institutional Ownership 82.5% 93.1% 51%
Float (Mil) 1.5 42.2 4%
Beta -0.11 0.94 4%
Avg Daily Volume (000s) 176 482 44%
Price Change
(52-week)
41.1% 59.9% 77%
Growth PTN Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 14.1% na
Net Income (5yr) 5.0% (10.1%) 47%
EPS (5yr) 23.1% 15.9% 73
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) (15.6%) (15.6%) 48%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 2 2 2
Current EPS ($1.125) ($2.990) ($2.430)
Month Ago EPS ($1.125) ($2.990) ($2.430)
# Rev Up 0 0 0
# Rev Down 1 1 1
Three Months Ago EPS ($1.125) ($2.990) ($2.430)
Year/Year Chg 207.4% (90.7%) (89.5%)
Financials PTN Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $13 $37 10%
Net Income (TTM) (Mil) ($6) ($43) 32%
EPS (TTM) ($3.044) ($1.500) 11%
Operating Cash Flow (TTM) (Mil) ($15) ($31) 17%
Net Cash Flow (TTM) (Mil) na $2 na
Long-Term Debt (Q1) (Mil) $0 $4 10%
Enterprise Value (Q1) (Mil) $12 $190 8%
Valuation PTN Industry
Median
Percentile
(All Stocks)
P/B 2.13 2.84 52%
P/E na 20.2 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.0 na
Ratios PTN Industry
Median
Percentile
(All Stocks)
Gross Margin 4.3% 66.9% 6%
Net Margin (48.5%) (74.2%) 12%
ROA (73.7%) (47.7%) 8%
ROE (297.2%) (55.0%) 3%
Liabilities to Assets 19.9% 29.8% 13%
F-Score 2 3 7%

Palatin Technologies, Inc. did not pass any screens on 9/4/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors